Atalanta Sosnoff Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1M | Sell |
31,756
-11,939
| -27% | -$5.32M | 0.29% | 48 |
|
|
2025
Q1 | $21.2M | Sell |
43,695
-1,507
| -3% | -$731K | 0.51% | 48 |
|
|
2024
Q4 | $18.2M | Sell |
45,202
-74,236
| -62% | -$29.9M | 0.4% | 48 |
|
|
2024
Q3 | $55.5M | Sell |
119,438
-41,817
| -26% | -$19.4M | 1.19% | 29 |
|
|
2024
Q2 | $75.6M | Sell |
161,255
-6,800
| -4% | -$3.19M | 1.7% | 15 |
|
|
2024
Q1 | $70.2M | Sell |
168,055
-7,606
| -4% | -$3.18M | 1.62% | 19 |
|
|
2023
Q4 | $71.5M | Buy |
175,661
+54,043
| +44% | +$22M | 1.84% | 16 |
|
|
2023
Q3 | $42.3M | Sell |
121,618
-2,757
| -2% | -$959K | 1.25% | 29 |
|
|
2023
Q2 | $43.8M | Buy |
124,375
+3,242
| +3% | +$1.14M | 1.19% | 29 |
|
|
2023
Q1 | $38.2M | Buy |
121,133
+8,899
| +8% | +$2.8M | 1.11% | 37 |
|
|
2022
Q4 | $32.4M | Sell |
112,234
-11,420
| -9% | -$3.3M | 1% | 42 |
|
|
2022
Q3 | $35.8M | Buy |
+123,654
| New | +$35.8M | 1.13% | 33 |
|
|
2020
Q2 | – | Sell |
-71,310
| Closed | -$17M | – | 112 |
|
|
2020
Q1 | $17M | Sell |
71,310
-1,535
| -2% | -$365K | 0.6% | 54 |
|
|
2019
Q4 | $16M | Sell |
72,845
-137,136
| -65% | -$30M | 0.47% | 56 |
|
|
2019
Q3 | $35.6M | Sell |
209,981
-6,134
| -3% | -$1.04M | 1.15% | 36 |
|
|
2019
Q2 | $39.6M | Sell |
216,115
-7,019
| -3% | -$1.29M | 1.25% | 34 |
|
|
2019
Q1 | $41M | Sell |
223,134
-82,338
| -27% | -$15.1M | 1.28% | 37 |
|
|
2018
Q4 | $50.6M | Sell |
305,472
-1,351
| -0.4% | -$224K | 1.84% | 21 |
|
|
2018
Q3 | $59.1M | Sell |
306,823
-527
| -0.2% | -$102K | 1.77% | 21 |
|
|
2018
Q2 | $52.2M | Sell |
307,350
-257,433
| -46% | -$43.8M | 1.72% | 24 |
|
|
2018
Q1 | $92M | Buy |
564,783
+93,641
| +20% | +$15.3M | 3.07% | 8 |
|
|
2017
Q4 | $70.6M | Buy |
471,142
+81,541
| +21% | +$12.2M | 2.29% | 16 |
|
|
2017
Q3 | $59.2M | Buy |
389,601
+101,517
| +35% | +$15.4M | 2.05% | 19 |
|
|
2017
Q2 | $37.1M | Buy |
+288,084
| New | +$37.1M | 1.31% | 31 |
|